News

Newsletter

November 19, 2020

ANVISA decides that a patent application related to pharmaceutical use of cannabinoids is not to be deemed as against public health

On November 17th, 2020, ANVISA’s Board of Directors (BoD) unanimously granted an administrative appeal for reassessment of prior consent of a patent application for an invention covering several cannabinoids (including THC) for pain treatment. The BoD considered that mere use of cannabinoids within the invention is not to be deemed as a threat to public health.
 
ANVISA’s BoD unanimously granted the administrative appeal and ordered COOPI to reassess the case. Rapporteur Director Antonio Barra Torres understood that denying prior consent only because an invention comprises the use of cannabinoids disregards relevant legal and sanitary aspects that should be taken into account. Director Alessandra Bastos Soares also noted that ANVISA’s Intellectual Property Coordination Office (COOPI) must take note of what has been decided by BoD on the subject, which is of great importance.
 
For further information, access here our full newsletter.
Back

Last related news

March 6, 2023

Brazilian Data Protection Authority approves the Regulation on Dosimetry and Application of Administrative Penalties

The Brazilian Data Protection Authority (“ANPD” or “Authority”) published, on February 28th, 2023, the Regulation on Dosimetry and Application of Administrative Penalties Brazilian Data Protection Authority approves the Regulation on Dosimetry and Application of Administrative Penalties

Ler notícia

January 17, 2023

The Future Legal Regulation Of Artificial Intelligence In Brazil

Several Bills are being debated in the Brazilian National Congress with the objective of regulating the development and use of artificial intelligence The Future Legal Regulation Of Artificial Intelligence In Brazil

Ler notícia

January 9, 2023

New flexibility on the remittance of royalty payments abroad

In the last days of December 2022, new regulations entered into force easing up the remittance of royalty payments abroad. However, local New flexibility on the remittance of royalty payments abroad

Ler notícia